Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18842582rdf:typepubmed:Citationlld:pubmed
pubmed-article:18842582lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C0142661lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C0162796lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1956003lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1418833lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1419980lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:18842582lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:18842582pubmed:issue51lld:pubmed
pubmed-article:18842582pubmed:dateCreated2008-12-16lld:pubmed
pubmed-article:18842582pubmed:abstractTextPre-mRNA splicing entails reversible phosphorylation of spliceosomal proteins. Recent work has revealed essential roles for Ser/Thr phosphatases, such as protein phosphatase-1 (PP1), in splicing, but how these phosphatases are regulated is largely unknown. We show that nuclear inhibitor of PP1 (NIPP1), a major PP1 interactor in the vertebrate nucleus, recruits PP1 to Sap155 (spliceosome-associated protein 155), an essential component of U2 small nuclear ribonucleoprotein particles, and promotes Sap155 dephosphorylation. C-terminally truncated NIPP1 (NIPP1-DeltaC) formed a hyper-active holoenzyme with PP1, rendering PP1 minimally phosphorylated on an inhibitory site. Forced expression of NIPP1-WT and -DeltaC resulted in slight and severe decreases in Sap155 hyperphosphorylation, respectively, and the latter was accompanied with inhibition of splicing. PP1 overexpression produced similar effects, whereas small interfering RNA-mediated NIPP1 knockdown enhanced Sap155 hyperphosphorylation upon okadaic acid treatment. NIPP1 did not inhibit but rather stimulated Sap155 dephosphorylation by PP1 in vitro through facilitating Sap155/PP1 interaction. Further analysis revealed that NIPP1 specifically recognizes hyperphosphorylated Sap155 thorough its Forkhead-associated domain and dissociates from Sap155 after dephosphorylation by associated PP1. Thus NIPP1 works as a molecular sensor for PP1 to recognize phosphorylated Sap155.lld:pubmed
pubmed-article:18842582pubmed:languageenglld:pubmed
pubmed-article:18842582pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:citationSubsetIMlld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18842582pubmed:statusMEDLINElld:pubmed
pubmed-article:18842582pubmed:monthDeclld:pubmed
pubmed-article:18842582pubmed:issn0021-9258lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:KosekiHaruhik...lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:SatoMasamiMlld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:KawamuraTakes...lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:BollenMathieu...lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:BeullensMoniq...lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:IsonoKyoichiKlld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:ShimaHiroshiHlld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:KikuchiKunimi...lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:MitsuhashiShi...lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:TanumaNobuhir...lld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:NomuraMiyukiMlld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:KimSei-EunSElld:pubmed
pubmed-article:18842582pubmed:authorpubmed-author:TsubakiYaoYlld:pubmed
pubmed-article:18842582pubmed:issnTypePrintlld:pubmed
pubmed-article:18842582pubmed:day19lld:pubmed
pubmed-article:18842582pubmed:volume283lld:pubmed
pubmed-article:18842582pubmed:ownerNLMlld:pubmed
pubmed-article:18842582pubmed:authorsCompleteYlld:pubmed
pubmed-article:18842582pubmed:pagination35805-14lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:meshHeadingpubmed-meshheading:18842582...lld:pubmed
pubmed-article:18842582pubmed:year2008lld:pubmed
pubmed-article:18842582pubmed:articleTitleNuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155).lld:pubmed
pubmed-article:18842582pubmed:affiliationDivision of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori 981-1293, Japan. tanuma-no872@pref.miyagi.jplld:pubmed
pubmed-article:18842582pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18842582pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5511entrezgene:pubmedpubmed-article:18842582lld:entrezgene
entrez-gene:23451entrezgene:pubmedpubmed-article:18842582lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18842582lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18842582lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18842582lld:pubmed